Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Corinne Jenkins's Stock Ratings
Goldman Sachs Analyst
Corinne Jenkins is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-3.31%
Smart Score
Overall Average Return Percentile
27th
Number of Ratings
81
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/12/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | 38.08% | $141 → $157 | Maintains | Buy | Get Alert | |
| 10/21/2025 | IDYA | Buy Now | IDEAYA Biosciences | $33.90 | -11.5% | $27 → $30 | Maintains | Neutral | Get Alert | |
| 10/17/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | 22.25% | $157 → $139 | Maintains | Buy | Get Alert | |
| 09/24/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | 21.37% | $105 → $138 | Maintains | Buy | Get Alert | |
| 09/18/2025 | ROIV | Buy Now | Roivant Sciences | $22.07 | 8.77% | $20 → $24 | Maintains | Buy | Get Alert | |
| 07/10/2025 | GERN | Buy Now | Geron | $1.36 | -26.74% | → $1 | Reinstates | → Sell | Get Alert | |
| 12/05/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -41.95% | $59 → $66 | Maintains | Buy | Get Alert | |
| 11/05/2024 | TGTX | Buy Now | TG Therapeutics | $31.28 | -29.67% | $20 → $22 | Maintains | Neutral | Get Alert | |
| 08/08/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $77 → $74 | Maintains | Neutral | Get Alert | |
| 08/07/2024 | TGTX | Buy Now | TG Therapeutics | $31.28 | -36.06% | $18 → $20 | Maintains | Neutral | Get Alert | |
| 05/14/2024 | FULC | Buy Now | Fulcrum Therapeutics | $13.02 | 15.21% | $6 → $15 | Upgrade | Neutral → Buy | Get Alert | |
| 05/13/2024 | FULC | Buy Now | Fulcrum Therapeutics | $13.02 | 15.21% | → $15 | Upgrade | Neutral → Buy | Get Alert | |
| 05/13/2024 | IDYA | Buy Now | IDEAYA Biosciences | $33.90 | 35.69% | $53 → $46 | Maintains | Buy | Get Alert | |
| 04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $67 → $77 | Maintains | Neutral | Get Alert | |
| 04/03/2024 | ROIV | Buy Now | Roivant Sciences | $22.07 | -18.42% | $16 → $18 | Maintains | Buy | Get Alert | |
| 03/15/2024 | GERN | Buy Now | Geron | $1.36 | 266.3% | $4 → $5 | Maintains | Buy | Get Alert | |
| 02/29/2024 | TGTX | Buy Now | TG Therapeutics | $31.28 | -58.44% | $12 → $13 | Maintains | Neutral | Get Alert | |
| 01/26/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -54.27% | $42 → $52 | Maintains | Buy | Get Alert | |
| 01/26/2024 | IDYA | Buy Now | IDEAYA Biosciences | $33.90 | 56.34% | $36 → $53 | Maintains | Buy | Get Alert | |
| 01/25/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -54.27% | $42 → $52 | Maintains | Buy | Get Alert | |
| 01/25/2024 | IDYA | Buy Now | IDEAYA Biosciences | $33.90 | 56.34% | $36 → $53 | Maintains | Buy | Get Alert | |
| 01/24/2024 | ALT | Buy Now | Altimmune | $5.36 | 142.76% | → $13 | Reinstates | → Neutral | Get Alert | |
| 01/18/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $58 → $64 | Maintains | Neutral | Get Alert | |
| 01/09/2024 | HRMY | Buy Now | Harmony Biosciences | $39.22 | -28.61% | $25 → $28 | Maintains | Sell | Get Alert | |
| 12/07/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -63.06% | $38 → $42 | Maintains | Buy | Get Alert | |
| 11/29/2023 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $47 → $52 | Maintains | Buy | Get Alert | |
| 11/15/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | $10 → $9 | Maintains | Neutral | Get Alert | |
| 11/03/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $332 → $296 | Maintains | Buy | Get Alert | |
| 09/27/2023 | ROIV | Buy Now | Roivant Sciences | $22.07 | -27.49% | $14 → $16 | Maintains | Buy | Get Alert | |
| 09/26/2023 | HRMY | Buy Now | Harmony Biosciences | $39.22 | -20.96% | $40 → $31 | Maintains | Sell | Get Alert | |
| 09/25/2023 | HRMY | Buy Now | Harmony Biosciences | $39.22 | -20.96% | $40 → $31 | Downgrade | Neutral → Sell | Get Alert | |
| 09/13/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | $6 → $10 | Maintains | Neutral | Get Alert | |
| 09/12/2023 | IDYA | Buy Now | IDEAYA Biosciences | $33.90 | 9.14% | $31 → $37 | Maintains | Buy | Get Alert | |
| 09/12/2023 | GERN | Buy Now | Geron | $1.36 | 193.04% | → $4 | Upgrade | Neutral → Buy | Get Alert | |
| 08/15/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.92 | 108.82% | $12 → $4 | Maintains | Neutral | Get Alert | |
| 08/03/2023 | TGTX | Buy Now | TG Therapeutics | $31.28 | -61.64% | $16 → $12 | Maintains | Neutral | Get Alert | |
| 08/02/2023 | TGTX | Buy Now | TG Therapeutics | $31.28 | -61.64% | $16 → $12 | Upgrade | Sell → Neutral | Get Alert | |
| 07/25/2023 | TGTX | Buy Now | TG Therapeutics | $31.28 | -48.85% | $10 → $16 | Maintains | Sell | Get Alert | |
| 07/24/2023 | TGTX | Buy Now | TG Therapeutics | $31.28 | -48.85% | $10 → $16 | Maintains | Sell | Get Alert | |
| 07/20/2023 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $43 → $49 | Maintains | Buy | Get Alert | |
| 05/26/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.92 | 1205.14% | $28 → $25 | Maintains | Neutral | Get Alert | |
| 05/24/2023 | IDYA | Buy Now | IDEAYA Biosciences | $33.90 | -5.6% | → $32 | Initiates | → Buy | Get Alert | |
| 03/28/2023 | GERN | Buy Now | Geron | $1.36 | 119.78% | → $3 | Initiates | → Neutral | Get Alert | |
| 03/22/2023 | ALT | Buy Now | Altimmune | $5.36 | 12.04% | $20 → $6 | Downgrade | Buy → Neutral | Get Alert | |
| 03/15/2023 | RAPT | Buy Now | RAPT Therapeutics | $35.70 | -35.58% | $27 → $23 | Maintains | Buy | Get Alert | |
| 03/07/2023 | ACRS | Buy Now | Aclaris Therapeutics | $3.23 | 549.15% | $25 → $21 | Maintains | Buy | Get Alert | |
| 03/02/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -60.42% | $40 → $45 | Maintains | Buy | Get Alert | |
| 02/27/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | $2 → $6 | Maintains | Neutral | Get Alert | |
| 02/23/2023 | HRMY | Buy Now | Harmony Biosciences | $39.22 | 9.64% | $49 → $43 | Maintains | Neutral | Get Alert | |
| 02/22/2023 | HRMY | Buy Now | Harmony Biosciences | $39.22 | 9.64% | $49 → $43 | Maintains | Neutral | Get Alert | |
| 01/26/2023 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $40 → $45 | Maintains | Buy | Get Alert | |
| 01/26/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -64.82% | $35 → $40 | Maintains | Buy | Get Alert | |
| 01/26/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.92 | 1257.35% | $16 → $26 | Maintains | Neutral | Get Alert | |
| 01/19/2023 | ROIV | Buy Now | Roivant Sciences | $22.07 | -50.15% | $10 → $11 | Maintains | Buy | Get Alert | |
| 12/30/2022 | TGTX | Buy Now | TG Therapeutics | $31.28 | -80.82% | $4 → $6 | Maintains | Sell | Get Alert | |
| 12/20/2022 | TERN | Buy Now | Terns Pharma | $44.12 | -68.26% | $9 → $14 | Maintains | Buy | Get Alert | |
| 12/01/2022 | ALT | Buy Now | Altimmune | $5.36 | 273.48% | → $20 | Initiates | → Buy | Get Alert | |
| 12/01/2022 | ACRS | Buy Now | Aclaris Therapeutics | $3.23 | 672.8% | → $25 | Initiates | → Buy | Get Alert | |
| 12/01/2022 | RAPT | Buy Now | RAPT Therapeutics | $35.70 | -24.38% | → $27 | Initiates | → Buy | Get Alert | |
| 12/01/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.92 | 735.29% | → $16 | Upgrade | Sell → Neutral | Get Alert | |
| 10/21/2022 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $51 → $44 | Maintains | Buy | Get Alert | |
| 10/21/2022 | HRMY | Buy Now | Harmony Biosciences | $39.22 | 30.04% | $58 → $51 | Maintains | Neutral | Get Alert | |
| 09/28/2022 | TERN | Buy Now | Terns Pharma | $44.12 | -79.6% | $4 → $9 | Maintains | Buy | Get Alert | |
| 09/08/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -72.74% | $28 → $31 | Maintains | Buy | Get Alert | |
| 08/22/2022 | GRTS | Buy Now | Gritstone Bio | — | — | → $2 | Downgrade | Neutral → Sell | Get Alert | |
| 08/22/2022 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $64 → $49 | Downgrade | Buy → Neutral | Get Alert | |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $228 → $278 | Maintains | Buy | Get Alert | |
| 08/08/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.70 | -75.37% | → $28 | Upgrade | Neutral → Buy | Get Alert | |
| 07/13/2022 | HRMY | Buy Now | Harmony Biosciences | $39.22 | 40.23% | → $55 | Downgrade | Buy → Neutral | Get Alert | |
| 05/24/2022 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $76 → $82 | Maintains | Buy | Get Alert | |
| 05/24/2022 | ROIV | Buy Now | Roivant Sciences | $22.07 | -45.62% | $15 → $12 | Maintains | Buy | Get Alert | |
| 05/24/2022 | RDUS | Buy Now | Radius Health | — | — | $9 → $8 | Maintains | Neutral | Get Alert | |
| 05/24/2022 | AMAM | Buy Now | Ambrx Biopharma | — | — | $6 → $4 | Maintains | Neutral | Get Alert | |
| 05/09/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.92 | 422.06% | $17 → $10 | Maintains | Sell | Get Alert | |
| 02/28/2022 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $6 | Initiates | → Neutral | Get Alert | |
| 02/16/2022 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | → $64 | Initiates | → Buy | Get Alert | |
| 12/15/2021 | ATHA | Buy Now | Athira Pharma | $3.92 | 308.42% | → $16 | Initiates | → Neutral | Get Alert | |
| 12/15/2021 | ROIV | Buy Now | Roivant Sciences | $22.07 | -32.02% | → $15 | Initiates | → Buy | Get Alert | |
| 12/10/2021 | RDUS | Buy Now | Radius Health | — | — | $33 → $12 | Downgrade | Buy → Neutral | Get Alert | |
| 11/15/2021 | BTAI | Buy Now | BioXcel Therapeutics | $1.92 | 1152.94% | $55 → $24 | Downgrade | Buy → Sell | Get Alert | |
| 10/13/2020 | ATHA | Buy Now | Athira Pharma | $3.92 | 1252.9% | → $53 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved